134 related articles for article (PubMed ID: 31705142)
1. Antibiofilm and antibacterial activities of repurposing auranofin against Bacteroides fragilis.
Jang HI; Eom YB
Arch Microbiol; 2020 Apr; 202(3):473-482. PubMed ID: 31705142
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and antibiofilm effects of α-humulene against
Jang HI; Rhee KJ; Eom YB
Can J Microbiol; 2020 Jun; 66(6):389-399. PubMed ID: 32073898
[TBL] [Abstract][Full Text] [Related]
3. Effect of Probiotic
Shin DS; Rhee KJ; Eom YB
J Microbiol Biotechnol; 2020 Mar; 30(3):368-377. PubMed ID: 32066216
[TBL] [Abstract][Full Text] [Related]
4. Anti-biofilm and antimicrobial effects of zerumbone against Bacteroides fragilis.
Kim HR; Rhee KJ; Eom YB
Anaerobe; 2019 Jun; 57():99-106. PubMed ID: 30953693
[TBL] [Abstract][Full Text] [Related]
5. Repurposing auranofin to combat uropathogenic Escherichia coli biofilms.
Jang HI; Eom YB
J Appl Microbiol; 2019 Aug; 127(2):459-471. PubMed ID: 31087803
[TBL] [Abstract][Full Text] [Related]
6. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.
Pumbwe L; Skilbeck CA; Nakano V; Avila-Campos MJ; Piazza RM; Wexler HM
Microb Pathog; 2007; 43(2-3):78-87. PubMed ID: 17524609
[TBL] [Abstract][Full Text] [Related]
7. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Bacteroides fragilis resistance to metronidazole.
Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis.
Silva CMG; Silva DNDS; Costa SBD; Almeida JSS; Boente RF; Teixeira FL; Domingues RMCP; Lobo LA
Braz J Microbiol; 2018; 49(1):200-206. PubMed ID: 28847541
[TBL] [Abstract][Full Text] [Related]
10. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
Eitel Z; Sóki J; Urbán E; Nagy E;
Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility.
Silva JO; Martins Reis AC; Quesada-Gómez C; Pinheiro AQ; Freire RS; Oriá RB; de Carvalho CB
Anaerobe; 2014 Aug; 28():24-8. PubMed ID: 24799339
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates.
Pumbwe L; Chang A; Smith RL; Wexler HM
J Antimicrob Chemother; 2006 Sep; 58(3):543-8. PubMed ID: 16840432
[TBL] [Abstract][Full Text] [Related]
14. Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp.
She P; Liu Y; Wang Y; Tan F; Luo Z; Wu Y
J Appl Microbiol; 2020 Jan; 128(1):88-101. PubMed ID: 31509623
[TBL] [Abstract][Full Text] [Related]
15. The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.
Goldstein EJ; Citron DM; Tyrrell KL; Leoncio ES; Merriam CV
Anaerobe; 2017 Feb; 43():1-3. PubMed ID: 27713022
[TBL] [Abstract][Full Text] [Related]
16. Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis.
Pumbwe L; Skilbeck CA; Wexler HM
Microb Ecol; 2008 Oct; 56(3):412-9. PubMed ID: 18188535
[TBL] [Abstract][Full Text] [Related]
17. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
18. The Bacteroides fragilis pathogenicity island links virulence and strain competition.
Casterline BW; Hecht AL; Choi VM; Bubeck Wardenburg J
Gut Microbes; 2017 Jul; 8(4):374-383. PubMed ID: 28632016
[TBL] [Abstract][Full Text] [Related]
19. Enterotoxigenic and non-enterotoxigenic Bacteroides fragilis from fecal microbiota of children.
Ignacio A; Fernandes MR; Avila-Campos MJ; Nakano V
Braz J Microbiol; 2015; 46(4):1141-5. PubMed ID: 26691473
[TBL] [Abstract][Full Text] [Related]
20. First Hungarian case of an infection caused by multidrug-resistant Bacteroides fragilis strain.
Urbán E; Horváth Z; Sóki J; Lázár G
Anaerobe; 2015 Feb; 31():55-8. PubMed ID: 25285854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
